Risk of recurrence and long-term mortality following radical cystectomy for bladder cancer

References

• Martini A, Sfakianos JP, Renström-Koskela L, et al. The natural history of untreated muscle-invasive bladder cancer: natural history of untreated MIBC. BJU Int. 2020;125(2):270–275.
   PubMed Web of Science ®Google Scholar
• Alfred Witjes J, Lebret T, Compérat EM, et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–475.
   PubMed Web of Science ®Google Scholar
• Novotny V, Hakenberg OW, Wiessner D, et al. Perioperative complications of radical cystectomy in a contemporary series. Eur Urol. 2007;51(2):397–402.
   PubMed Web of Science ®Google Scholar
• Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology. 2006;68(1):58–64.
   PubMed Web of Science ®Google Scholar
• Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-Term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–675.
   PubMed Web of Science ®Google Scholar
• Life expectancy at age 60 (years) [Internet]; [cited 2021 Oct 18]. Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/life-expectancy-at-age-60-(years. ).
   Google Scholar
• Maibom SL, Røder MA, Poulsen AM, et al. Morbidity and days alive and out of hospital within 90 days following radical cystectomy for bladder cancer. Eur Urol. 2021;28:1–8.
   Web of Science ®Google Scholar
• Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45(2):228–247.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Humphrey PA, Moch H, Cubilla AL, et al. The 2016 WHO classification of tumours of the urinary system and male genital Organs-Part B: prostate and bladder tumours. Eur Urol. 2016;70(1):106–119.
   PubMed Web of Science ®Google Scholar
• Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Control Clin Trials. 1996;17(4):343–346.
   PubMedGoogle Scholar
• Chang SS, Bochner BH, Chou R, et al. Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol. 2017;198(3):552–559.
   PubMed Web of Science ®Google Scholar
• Fahmy O, Khairul-Asri MG, Schubert T, et al. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer. Urol Oncol-Semin Iri. 2018;36(2):43–53.
   PubMed Web of Science ®Google Scholar
• Shelley M, Barber J, Wilt TJ, et al. Surgery versus radiotherapy for muscle invasive bladder cancer. Cochrane DB Syst Rev. 2001;2001:CD002079.
   Google Scholar
• Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome. J Clin Oncol. 1998;16(4):1298–1301.
   PubMed Web of Science ®Google Scholar
• Hansen E, Larsson H, Nørgaard M, et al. The danish bladder cancer database. Clin Epidemiol. 2016;8:439–443.
   PubMed Web of Science ®Google Scholar
• Häggström C, Garmo H, de Luna X, et al. Survival after radiotherapy versus radical cystectomy for primary muscle-invasive bladder cancer: A Swedish nationwide population-based cohort study. Cancer Med. 2019;8(5):2196–2204.
   PubMed Web of Science ®Google Scholar
• Daehlin L, Haukaas S, Maartmann-Moe H, et al. Survival after radical treatment for transitional cell carcinoma of the bladder. Eur J Surg Oncol. 1999;25(1):66–70.
   PubMedGoogle Scholar
• Hautmann RE, de Petriconi RC, Pfeiffer C, et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-Term results in 1100 patients. Eur Urol. 2012;61(5):1039–1047.
   PubMed Web of Science ®Google Scholar
• Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008;180(1):121–127.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Karakiewicz PI, Palapattu GS, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the bladder cancer research consortium. J Urol. 2006;176(6 Pt 1):2414–2422.
   PubMed Web of Science ®Google Scholar
• Welty CJ, Sanford TH, Wright JL, et al. The cancer of the bladder risk assessment (COBRA) score: estimating mortality after radical cystectomy: predicting prognosis after cystectomy. Cancer. 2017;123(23):4574–4582.
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21(4):690–696.
   PubMed Web of Science ®Google Scholar
• Jahnson S, Hosseini Aliabad A, Holmäng S, et al. Swedish national registry of urinary bladder cancer: no difference in relative survival over time despite more aggressive treatment. Scand J Urol. 2016;50(1):14–20.
   PubMed Web of Science ®Google Scholar
• Strope SA, Chang S-H, Chen L, et al. Survival impact of followup care after radical cystectomy for bladder cancer. J Urol. 2013;190(5):1698–1703.
   PubMed Web of Science ®Google Scholar
• Soave A, Riethdorf S, Dahlem R, et al. A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy: circulating tumor cells and adjuvant chemotherapy after radical cystectomy. Int J Cancer. 2017;140(2):381–389.
   PubMed Web of Science ®Google Scholar
• Vandekerkhove G, Lavoie J-M, Annala M, et al. Plasma ctDNA is a tumor tissue surrogate and enables clinical-genomic stratification of metastatic bladder cancer. Nat Commun. 2021;12(1):184.
   PubMed Web of Science ®Google Scholar
• Häggström C, Liedberg F, Hagberg O, et al. Cohort profile: the Swedish National Register of Urinary Bladder Cancer (SNRUBC) and the Bladder Cancer Data Base Sweden (BladderBaSe). BMJ Open. 2017;7(9):e016606.
   PubMed Web of Science ®Google Scholar
• Gore JL, Litwin MS, Lai J, et al. Use of radical cystectomy for patients with invasive bladder cancer. J Natl Cancer Inst. 2010;102(11):802–811.
   PubMedGoogle Scholar
• File:Smoking prevalence, by country, 2012 and 2017 (% of population aged 15 or over).png [Internet]. [cited 2021 Dec 23]. Available from: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=File:Smoking_prevalence,_by_country,_2012_and_2017_(%25_of_population_aged_15_or_over).png.
   Google Scholar